Trial NCT04091750

View at ClinicalTrials.gov 
Org. Study IDs: STUDY00000904

Last trial update was posted on 2023-08-14

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

futility stage with the first 14 subjects completed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID